Initial Development. A. Landlord will cause Landlord's Improvements depicted on the Site Plan attached hereto as Exhibit B to be constructed in accordance with the plans and specifications and construction contracts described on Exhibit C hereto.
Initial Development. Legal and other fees, leasing commissions, advertising expenses and other costs incurred in connection with acquisition of the land, or the original development or original leasing of the Project.
Initial Development. Boxlot shall develop the Co-Branded Pages using the Page Templates and take all other steps required to co-brand the Service in accordance with Exhibit A. In addition, if theglobe is passing any user data to Boxlot, theglobe's standard Automatic Partner Registration procedure shall apply, and Boxlot shall perform the development necessary to use such procedure. The current Automatic Partner Registration procedure is described in Exhibit D. Boxlot shall make the Service implementation available to theglobe on the Shadow Site prior to making it publicly available. Boxlot shall not make the initial Service implementation publicly available without theglobe's prior written approval. Unless otherwise specified, each party shall be responsible for all development, hosting and other costs associated with the pages living on their servers and all emails they send.
Initial Development. Each Party agrees to work with the other to design, develop and commence operation of the Planning System and to provide any Deliverables relating to the Planning System for which it responsible pursuant to the Development Schedule, which is attached as Exhibit A and the parties shall mutually develop a schedule for future applications including but not limited to the Planning Application Subscription Model, which shall be appended as Exhibits hereto.
Initial Development. The initial development effort under the Research Project shall focus on Product One; provided, that Collagen shall, at its discretion, apply resources covered by the initial Project Budget to Product Two as such resources become available. As of the Effective Date, the parties have agreed upon an initial Project Plan and Project Budget which covers Product One.
Initial Development. The Initial Development Plan is contained in a letter delivered by AGIX to AstraZeneca on the date hereof.
Initial Development. 6 3.1. Interface Development.......................................................................... 6 3.2. ALST Provision of Information.................................................................. 6 3.3. Completion of Initial Product Development...................................................... 7 3.4. Ownership...................................................................................... 7
Initial Development. The Parties will focus their initial efforts on the development of Licensed Products to treat psoriasis. In addition, the Parties shall develop Licensed Products for Organ Transplant Indications as follows: (i) XOMA and Genentech each have the right to opt-in or opt-out of each Organ Transplant Indication on an Indication by Indication basis in accordance with the provisions set forth in Section 5.1; (ii) Genentech shall have a right to opt-in to an Organ Transplant Indication on an Indication by Indication basis as set forth in Sections 5.4(a) and 5.4(d) provided however that Genentech shall not be obligated to pay an opt-in fee and (iii) with respect to the renal Organ Transplant Indication, the Parties acknowledge that subsequent to the Effective Date and prior to the Restatement Date the Parties mutually agreed to discontinue present development efforts and that in the event that either Party proposes to resume development of the renal Organ Transplant Indication, the rights and obligations of the Parties shall be governed by Article 5.
Initial Development. Development shall be governed by a Development Plan, which shall contain a detailed description of the proposed overall program of Development of each Product and the responsibilities of each Party with respect to such program of Development. Attached hereto as Schedule 2.2 is a Development Plan covering the anticipated activities of the Parties through the completion of the clinical trials described therein (the “Initial Development”). The Steering Committee may, from time-to-time, update or modify the Development Plan including, without limitation, the anticipated timelines and allocation of responsibilities to the Parties; provided, however, that any material modification to the Development Plan shall require the written agreement of a duly authorized officer of each Party; provided further, however, that any modification pursuant to which Novacea does not carry out a Phase 1 or Phase 2 clinical trial otherwise called for in the Development Plan shall be regarded as a material modification for these purposes. The Development Plan, and any update or modification thereto, shall incorporate an illustrative, non-binding budget with respect to the activities contemplated in the forthcoming 12 month period.
Initial Development. The Parties agree that the initial Development Services shall commence upon written agreement by Accuray and CyberHeart to a Statement of Work that defines the Development Services to be performed by Accuray using Reasonable Commercial Efforts. Each Statement of Work shall, to the extent requested by CyberHeart, provide for Deliverables (including without limitation by way of CyberHeart Improvements) as described therein.
